⌘K

Home/Filings/4/0000905718-21-000576

4//SEC Filing

Floyd Eric 4

Accession 0000905718-21-000576

CIK 0001708331other

View on SEC.gov Company Profile

Filed

Apr 8, 8:00 PM ET

Accepted

Apr 9, 5:09 PM ET

Size

5.2 KB

Accession

0000905718-21-000576

Insider Transaction Report

Form 4

Period: 2021-04-07

Virpax Pharmaceuticals, Inc.VRPX

Director

Transactions

Award
Stock Option (right to buy)
2021-04-07+11,216→ 11,216 total
Exercise: $4.62From: 2022-04-07Exp: 2031-04-07→ Common Stock (11,216 underlying)

Documents

1 file

4
floyd_fm4april72021.xmlPrimary

Issuer

Virpax Pharmaceuticals, Inc.

CIK 0001708331

Entity typeother

Related Parties

1

filerCIK 0001818469

Filing Metadata

Form type: 4
Filed: Apr 8, 8:00 PM ET
Accepted: Apr 9, 5:09 PM ET
Size: 5.2 KB

View on SEC.gov